Wednesday, 28 October 2020

Kool-ex, IndoSpace to build temperature-controlled pharma distribution centres

24 September 2020 | News

Warehouse transaction deal between Kool-ex and IndoSpace led by CREDBERG Advisors

Kool-ex, a leading pharma cold chain logistics service provider with the largest reefer fleet of 350 vehicles based in Mumbai, is gearing up to become a full stack, end to end supply chain solutions provider to the pharma industry. The spread of services will include warehousing, secondary distribution, passive packaging, and blockchain for end to end tractability of pharma products, apart from its core existing business of providing temperature-controlled transportation.

For warehousing, Kool-ex has partnered with IndoSpace, the largest investor, developer and manager of industrial real estate and warehousing in India, to build customized, GDP/GWP compliant, temperature-controlled, Pharma Distribution Centres across the country. IndoSpace has the only pan-India network of Grade A warehouses in the country, and the partnership with Kool-ex will enable IndoSpace to venture into pharma warehousing.

Kool-ex and IndoSpace will jointly design and set up three warehouses in the first phase by 2021 in proximity to Mumbai, Delhi and Bangalore. At 42,000 pallet positions in each warehouse, each of these warehouses will be the largest standalone Cold Chain Facility in the country. Kool-ex has plans to set-up 10-11 warehouses by 2023 making it the largest Pharma storage footprint in the country.

Furthermore, these will be certified Green Warehouses with 100% solar back up. Kool-ex was advised by CREDBERG Advisors in forging this partnership with IndoSpace. 

Kool-ex is also set to offer complete Pharma passive packaging solutions - in partnership with TESSOL, a leading cold chain solutions provider - to design and supply Passive Cooling Boxes for intercity & Intra city movement of sensitive time bound, temp controlled medicines such as vaccines, insulins etc.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account